Finance Committee's Health Reform Vote Awaits New CBO Score
Executive Summary
From the drug industry's point of view, the health care reform bill emerging from the Senate Finance Committee has few negative surprises
You may also be interested in...
One Cost Of Cancer: The Rising Price Of Treatment
Given the debate surrounding the country's soaring health care costs, it's no surprise that cancer medicines - and their escalating prices - are coming under attack
One Cost Of Cancer: The Rising Price Of Treatment
Given the debate surrounding the country's soaring health care costs, it's no surprise that cancer medicines - and their escalating prices - are coming under attack
One Cost Of Cancer: The Rising Price Of Treatment
Cancer therapies hit 5 percent of total drug spending for the first time in first half of 2009, Medco says